NLM Logo

Dasatinib MeSH Descriptor Data 2024


MeSH Heading
Dasatinib
Tree Number(s)
D02.886.675.184
D03.383.129.708.198
D03.383.742.148
Unique ID
D000069439
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D000069439
Scope Note
A pyrimidine and thiazole derived ANTINEOPLASTIC AGENT and PROTEIN KINASE INHIBITOR of BCR-ABL KINASE. It is used in the treatment of patients with CHRONIC MYELOID LEUKEMIA who are resistant or intolerant to IMATINIB.
Entry Term(s)
(18F)-N-(2-chloro-6-methylphenyl)-2-(6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-ylamino)thiazole-5-carboxamide
BMS 354825
BMS-354825
BMS354825
N-(2-chloro-6-methylphenyl)-2-(6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-ylamino)thiazole-5-carboxamide
Sprycel
Pharm Action
Tyrosine Kinase Inhibitors
Antineoplastic Agents
Registry Number
RBZ1571X5H
Related Numbers
302962-49-8
Public MeSH Note
2016; DASATINIB was indexed under PYRIMIDINES and THIAZOLES 2004-2015
History Note
2016 (2004)
Date Established
2016/01/01
Date of Entry
2015/07/01
Revision Date
2023/08/04
Dasatinib Preferred
Sprycel Narrower
(18F)-N-(2-chloro-6-methylphenyl)-2-(6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-ylamino)thiazole-5-carboxamide Narrower
BMS 354825 Narrower
page delivered in 0.162s